{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:35:51Z","timestamp":1758814551224},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2418,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>Experiments were designed to determine the <jats:italic>in vivo <\/jats:italic> cell\u2010cycle phase of lymphocytes in secondary lymphoid follicles, and whether B\u2010cell proliferation and apoptosis occur within follicular dendritic cell (FDC)\u2010associated clusters. Using frozen serial sections of human tonsils, lymphoid follicles were stained to reveal histone H3\u2003mRNA, as an S\u2010phase marker, using <jats:italic>in situ <\/jats:italic> hybridization, and stained immunohistochemically with antibodies against cyclin E as a late G<jats:sub>1<\/jats:sub> phase marker, cyclin B1 and p34cdc2 as S\u2010G<jats:sub>2<\/jats:sub>\u2010M phase markers, and Ki\u201067 as a marker of cycling cells. Each LF was divided into five zones: mantle zone, outer zone, apical light zone, basal light zone and dark zone, with the help of haematoxylin and eosin staining, and a CD23 immunostain. The rate of occurrence of positively labelled cells was calculated by dividing the number of positive cells by the number of all cells in each zone. The cells that were positive for cyclin E, histone H3\u2003mRNA, cyclin B1, p34cdc2, and Ki\u201067 were found most frequently in the dark zone (54\u00b75\u00b16\u00b76%, 22\u00b70\u00b15\u00b77%, 36\u00b77\u00b114\u00b75%, 40\u00b70\u00b110\u00b72%, and 59\u00b70\u00b113\u00b74%, respectively), followed by the outer zone (52\u00b77\u00b17\u00b78%, 14\u00b79\u00b14\u00b71%, 22\u00b79\u00b19\u00b77%, 24\u00b79\u00b17\u00b79%, and 44\u00b76\u00b112\u00b73%, respectively), showing that both the outer zone and the dark zone contain many proliferating lymphocytes. Furthermore, FDC\u2010associated clusters and free lymphocytes were obtained from enucleated germinal centres, using enzymatic digestion. The rates of occurrence of cells that were positive for cyclin B1 and Ki\u201067 within the clusters (7\u00b72\u00b11\u00b79% and 37\u00b79\u00b110\u00b75%, respectively) were significantly lower than those of free lymphocytes outside the clusters (22\u00b72\u00b14\u00b70% and 62\u00b78\u00b114\u00b70%, respectively). The rates of occurrence of apoptotic bodies and cells within the clusters, as detected by <jats:italic>in situ<\/jats:italic> tailing or <jats:italic>in situ<\/jats:italic> nick translation (0\u00b72\u00b10\u00b74% and 0\u00b74\u00b10\u00b74%, respectively) were significantly lower than those outside the clusters (1\u00b71\u00b10\u00b73, 1\u00b76\u00b10\u00b75 %, respectively). These results suggest that FDC\u2010associated clusters are not the site of proliferation, and that they rarely contain apoptotic bodies and cells of B lymphocytes.<\/jats:p>","DOI":"10.1046\/j.1365-2567.1997.00203.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T14:43:34Z","timestamp":1068821014000},"page":"489-495","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proliferation and apoptosis of follicular lymphocytes: relationship to follicular dendritic cell\u2010associated clusters"],"prefix":"10.1111","volume":"90","author":[{"given":"H.","family":"ORUI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"YAMAKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"IMAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.1997.00203.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00203.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00203.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T05:02:57Z","timestamp":1694408577000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.1997.00203.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1046\/j.1365-2567.1997.00203.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.1997.00203.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]},"assertion":[{"value":"2003-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}